The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Janssen-Cilag; Pfizer; Roche; Sanofi
ImmunoSarc2: A Spanish Sarcoma Group (GEIS) phase Ib trial of doxorubicin and dacarbazine plus nivolumab in first line treatment of advanced leiomyosarcoma.
 
Javier Martin Broto
Consulting or Advisory Role - Amgen; Asofarma; Bayer; Boehringer Ingelheim; GlaxoSmithKline; Lilly; Novartis; PharmaMar; Roche; Tecnofarma
Speakers' Bureau - PharmaMar
Research Funding - Adaptimmune; Amgen (Inst); Arog (Inst); Ayala Pharmaceuticals (Inst); Bayer (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); CEBIOTEX (Inst); Celgene (Inst); Daiichi Sankyo (Inst); Deciphera (Inst); Eisai; Eisai (Inst); FORMA Therapeutics (Inst); GlaxoSmithKline (Inst); Immix BioPharma (Inst); InhibRx (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Lixte Biotechnology (Inst); Nektar (Inst); Novartis; Novartis (Inst); Pfizer (Inst); PharmaMar; PharmaMar (Inst); Philogen (Inst); PTC Therapeutics (Inst); Rain Therapeutics (Inst); SpringWorks Therapeutics (Inst)
Expert Testimony - Novartis; PharmaMar
Travel, Accommodations, Expenses - Pfizer; PharmaMar
 
Roberto Diaz Beveridge
No Relationships to Disclose
 
David Moura
Honoraria - Tecnofarma
Research Funding - Eisai (Inst); Immix BioPharma (Inst); Novartis (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - Bayer; Eisai; Pfizer; PharmaMar
 
Rafael Ramos
No Relationships to Disclose
 
Javier Martinez-Trufero
Consulting or Advisory Role - Boehringer Ingelheim Spain; Deciphera; Eisai; PharmaMar; Qinlock; Qinlock
Research Funding - Blueprint Medicines (Inst); Lilly (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - Merck; PharmaMar
 
Irene Carrasco-Garcia
No Relationships to Disclose
 
Antonio Lopez-Pousa
No Relationships to Disclose
 
Enrique Gonzalez -Billalabeitia
No Relationships to Disclose
 
Antonio Gutierrez
Consulting or Advisory Role - Abbvie; AstraZeneca Spain; Incyte; Janssen; Takeda
Speakers' Bureau - Abbvie; AstraZeneca Spain; Janssen; Takeda
 
Josefina Cruz Jurado
Consulting or Advisory Role - AstraZeneca; Bayer; DAICHII; Gilead Sciences; GlaxoSmithKline; Lilly; Novartis; Pfizer; PharmaMar; Roche; Seagen
Speakers' Bureau - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Eisai; Gilead Sciences; GlaxoSmithKline; Lilly; Novartis; Pfizer; PharmaMar; Pierre Fabre; Roche
Travel, Accommodations, Expenses - AstraZeneca; DAICHII; Gilead Sciences; Novartis; PharmaMar
 
Ana Sebio
Consulting or Advisory Role - Boehringer Ingelheim; Lilly O.; PharmaMar
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Boston Scientific; Eisai; Lilly O.; Merck; PharmaMar
 
Ana Herrero Heras
No Relationships to Disclose
 
Claudia Maria Valverde Morales
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Deciphera; GlaxoSmithKline; Lilly; Mundipharma; PharmaMar
Research Funding - Adaptimmune (Inst); ADC Therapeutics (Inst); Boehringer Ingelheim (Inst); Deciphera (Inst); Foghorn Therapeutics (Inst); GlaxoSmithKline (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Philogen (Inst)
Travel, Accommodations, Expenses - Bayer; Boehringer Ingelheim; PharmaMar; Rovi
 
Nadia Hindi
Honoraria - PharmaMar; Tecnofarma
Consulting or Advisory Role - GlaxoSmithKline; PharmaMar
Research Funding - Adaptimmune (Inst); Ayala Pharmaceuticals (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb/Pfizer (Inst); CEBIOTEX (Inst); Deciphera (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Immix BioPharma (Inst); InhibRx (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Lixte Biotechnology (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Philogen (Inst); PTC Therapeutics (Inst); Rain Therapeutics (Inst)
Travel, Accommodations, Expenses - PharmaMar